荣泰健康（603579）披露2025年持续督导现场检查报告，1月15日股价上涨0.33%

Core Viewpoint - Rongtai Health (603579) shows stable operational performance and compliance with regulatory requirements following a recent inspection by Wanhe Securities, indicating a positive outlook for the company [1]. Group 1: Stock Performance - As of January 15, 2026, Rongtai Health's stock closed at 27.71 yuan, up 0.33% from the previous trading day [1]. - The stock opened at 27.47 yuan, reached a high of 28.51 yuan, and a low of 27.18 yuan, with a trading volume of 3.92 billion yuan and a turnover rate of 6.9% [1]. Group 2: Regulatory Inspection - Wanhe Securities conducted a site inspection for the 2025 continuous supervision work from January 7 to 8, 2026 [2]. - The inspection covered aspects such as corporate governance, internal controls, information disclosure, use of raised funds, related party transactions, and operational status [1]. - The results indicated that the company's governance structure is sound, information disclosure is compliant, and the use of raised funds is regulated, with no violations found regarding the controlling shareholder's fund occupation [1].